To Join or Not to Join

By Steven Wiley To Join or Not to Join The benefits of membership to a scientific society are decreasing every year. Lately, I’m asking: Why bother? At about this time every year, I renew my memberships to several scientific societies, and every year I ask myself the same question: “Should I bother?” In years past, the answer was easy because being a member came with tangible benefits, such as inexpensive journals and the ability to sub

Written bySteven Wiley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

At about this time every year, I renew my memberships to several scientific societies, and every year I ask myself the same question: “Should I bother?” In years past, the answer was easy because being a member came with tangible benefits, such as inexpensive journals and the ability to submit abstracts to annual meetings. Nowadays, these perks don’t seem very important. Most society journals are freely available online, and the proliferation of scientific meetings has made it easier to find venues to present my current research. Thus, the frequency with which I ask that question—“should I bother?”—has steadily increased.

Most scientific societies were established to promote the development and acceptance of a particular field of research. More recently, the larger societies have expanded their roles to include lobbying for increases in research funding and providing career advice. Although these are worthwhile activities, I don’t need to belong to multiple scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies